Gotowe bibliografie tematyczne / Drug delivery systems

Gotowa bibliografia na temat „Drug delivery systems”

Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 30 lipca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Spis treści

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Drug delivery systems”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Drug delivery systems"

1

Sharma, Abhimanyu Rai, Binu Raina, Prabhjot Singh Bajwa, Pankaj Sharma, Anurag Bhargava i Shailesh Sharma. "Chronotherapeutic drug delivery systems". Asian Pacific Journal of Health Sciences 5, nr 2 (czerwiec 2018): 189–95. http://dx.doi.org/10.21276/apjhs.2018.5.2.36.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Langer, Robert. "Drug Delivery Systems". MRS Bulletin 16, nr 9 (wrzesień 1991): 47–49. http://dx.doi.org/10.1557/s0883769400056050.

Pełny tekst źródła
Streszczenie:
For many years, drug delivery systems were composed of simple pills, eyedrops, ointments, or intravenous solutions. Recently, materials have begun to play a major role in improving drug delivery. Drugs are now chemically attached to polymers, entrapped in small vesicles that are injected into the bloodstream, or put in pumps or polymeric materials that are placed in the body. These new materials-based systems are beginning to change the way drugs can be administered and, in so doing, have improved human health. This article provides a brief review of the major classes of drug delivery systems; a recent paper discusses these issues in detail.Chemically attaching a drug to a polymer may alter such properties as its distribution in the body, rate of appearance in certain tissues, solubility, or antigenicity. For example, drugs have been linked to soluble macromolecules such as proteins, polysaccharides, or synthetic polymers via degradable linkages. This alters the drug's size and other properties, resulting in a different bodily drug distribution pattern. One example involves coupling the antitumor agent neocarzinostatin to styrene-maleic acid copolymers. When this complex was injected intra-arterially in patients with liver cancer, tumor size decreased significantly. In animals, the antitumor agent, doxorubicin, bound to N(2-hydroxypropyl) methacrylamide copolymers reduced toxicity. The plasma half-life and the drug levels in the tumor increased while the concentrations in the rest of the body decreased.
Style APA, Harvard, Vancouver, ISO itp.
3

Berillo, Dmitriy, Adilkhan Yeskendir, Zharylkasyn Zharkinbekov, Kamila Raziyeva i Arman Saparov. "Peptide-Based Drug Delivery Systems". Medicina 57, nr 11 (5.11.2021): 1209. http://dx.doi.org/10.3390/medicina57111209.

Pełny tekst źródła
Streszczenie:
Peptide-based drug delivery systems have many advantages when compared to synthetic systems in that they have better biocompatibility, biochemical and biophysical properties, lack of toxicity, controlled molecular weight via solid phase synthesis and purification. Lysosomes, solid lipid nanoparticles, dendrimers, polymeric micelles can be applied by intravenous administration, however they are of artificial nature and thus may induce side effects and possess lack of ability to penetrate the blood-brain barrier. An analysis of nontoxic drug delivery systems and an establishment of prospective trends in the development of drug delivery systems was needed. This review paper summarizes data, mainly from the past 5 years, devoted to the use of peptide-based carriers for delivery of various toxic drugs, mostly anticancer or drugs with limiting bioavailability. Peptide-based drug delivery platforms are utilized as peptide–drug conjugates, injectable biodegradable particles and depots for delivering small molecule pharmaceutical substances (500 Da) and therapeutic proteins. Controlled drug delivery systems that can effectively deliver anticancer and peptide-based drugs leading to accelerated recovery without significant side effects are discussed. Moreover, cell penetrating peptides and their molecular mechanisms as targeting peptides, as well as stimuli responsive (enzyme-responsive and pH-responsive) peptides and peptide-based self-assembly scaffolds are also reviewed.
Style APA, Harvard, Vancouver, ISO itp.
4

K Purushotham i K Anie Vijetha. "A review on transdermal drug delivery system". GSC Biological and Pharmaceutical Sciences 22, nr 2 (28.02.2023): 245–55. http://dx.doi.org/10.30574/gscbps.2023.22.2.0053.

Pełny tekst źródła
Streszczenie:
In order to produce systemic effects, transdermal drug delivery systems (TDDS), commonly referred to as "patches," are dosage forms that are intended to spread a therapeutically active amount of medicine across the skin of a patient. Drugs that are applied topically are delivered using transdermal drug delivery devices. These are pharmaceutical preparations of varying sizes, containing one or more active ingredients, intended to be applied to the unbroken skin in order to deliver the active ingredient after passing through the skin barriers, and these avoid first pass metabolism. Today about 74% of drugs are taken orally and are not found effective as desired. To improve efficacy transdermal drug delivery system was emerged. In TDDS the drug easily penetrates into the skin and easily reaches the target site. To get around the problems with medicine delivery via oral route, transdermal drug delivery systems were developed. These systems have been utilized as secure and reliable drug delivery systems since 1981.
Style APA, Harvard, Vancouver, ISO itp.
5

Chavhan, Sarin A., Sushilkumar A. Shinde, Sandip B. Sapkal i Vinayak N. Shrikhande. "Herbal excipients in Novel Drug Delivery Systems". International Journal of Research and Development in Pharmacy & Life Sciences 6, nr 3 (kwiecień 2017): 2597–605. http://dx.doi.org/10.21276/ijrdpl.2278-0238.2017.6(3).2597-2605.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Ranade, Vasant V. "Drug Delivery Systems 5A. Oral Drug Delivery". Journal of Clinical Pharmacology 31, nr 1 (styczeń 1991): 2–16. http://dx.doi.org/10.1002/j.1552-4604.1991.tb01881.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Ranade, Vasant V. "Drug Delivery Systems. 6. Transdermal Drug Delivery". Journal of Clinical Pharmacology 31, nr 5 (maj 1991): 401–18. http://dx.doi.org/10.1002/j.1552-4604.1991.tb01895.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Ranade, Vasant V. "Drug Delivery Systems 5B. Oral Drug Delivery". Journal of Clinical Pharmacology 31, nr 2 (luty 1991): 98–115. http://dx.doi.org/10.1002/j.1552-4604.1991.tb03693.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Mali, Audumbar Digambar, Ritesh Bathe i Manojkumar Patil. "An updated review on transdermal drug delivery systems". International Journal of Advances in Scientific Research 1, nr 6 (30.07.2015): 244. http://dx.doi.org/10.7439/ijasr.v1i6.2243.

Pełny tekst źródła
Streszczenie:
Transdermal drug delivery systems (TDDS), also known as patches, are dosage forms designed to deliver a therapeutically effective amount of drug across a patients skin. In order to deliver therapeutic agents through the human skin for systemic effects, the comprehensive morphological, biophysical and physicochemical properties of the skin are to be considered. Transdermal delivery provides a leading edge over injectables and oral routes by increasing patient compliance and avoiding first pass metabolism respectively. Transdermal delivery not only provides controlled, constant administration of the drug, but also allows continuous input of drugs with short biological half-lives and eliminates pulsed entry into systemic circulation, which often causes undesirable side effects. The TDDS review articles provide valuable information regarding the transdermal drug delivery systems and its evaluation process details as a ready reference for the research scientist who is involved in TDDS. With the advancement in technology Pharma industries have trendified all its resources. Earlier we use convectional dosage form but now we use novel drug delivery system. One of greatest innovation of novel drug delivery is transdermal patch. The advantage of transdermal drug delivery system is that it is painless technique of administration of drugs.
Style APA, Harvard, Vancouver, ISO itp.
10

Polack, Alan, i Michael Roberts. "Drug delivery systems". Medical Journal of Australia 144, nr 6 (marzec 1986): 311–14. http://dx.doi.org/10.5694/j.1326-5377.1986.tb128383.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Drug delivery systems"

1

Apps, MIchael Garry. "Platinum anticancer drugs and drug delivery systems". Thesis, The University of Sydney, 2015. http://hdl.handle.net/2123/14409.

Pełny tekst źródła
Streszczenie:
In this thesis two different ways to improve platinum-based chemotherapy were investigated. The first was through the use of a new slow release clay-based drug delivery vehicle and the second through the design and synthesis of novel dinuclear platinum complexes. For the clay-based drug delivery research, the platinum anticancer complex [(1,10-phenanthroline)(1S,2S-diaminocyclohexane)platinum(II)] chloride, PHENSS, was loaded into montmorillonite (MMT) clay. The PHENSS was found to be incompletely burst released from the MMT. The MMT also had a negative effect on the in vitro cytotoxicity of PHENSS in the human breast cancer cell lines MCF-7 and MDA-MB-231. Overall the results demonstrate that MMT is not a suitable slow release vehicle for PHENSS. For the dinuclear platinum complex synthesis research, new bispyridine-based bridging ligands were synthesised using an amide coupling reaction. The bridging ligands were then reacted with transplatin to yield the dinuclear platinum complexes. The platinum complexes have potential application as anticancer agents and the synthetic method can be modified to produce other multinuclear complexes.
Style APA, Harvard, Vancouver, ISO itp.
2

Ketkar, Amol Sharad. "Polymeric drug delivery systems /". The Ohio State University, 1994. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487859879937796.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Zaher, Amir. "Remotely controlled drug delivery systems". Thesis, University of British Columbia, 2016. http://hdl.handle.net/2429/57611.

Pełny tekst źródła
Streszczenie:
Implantable drug delivery is becoming an increasingly important field of research, providing great potential for a wide range of flexible and low cost solutions for localized treatment of chronically debilitating diseases. This dissertation presents work that encompasses several approaches for the remote triggering, powering, and control of micro drug delivery devices and systems, designed with remote-controllability, minimal power requirements, biocompatibility, and the potential for minimally invasive implantation in mind. The control mechanisms used rely on microtechnology, nanotechnology, and electromagnetic power transfer to magnetic nanoparticles and magnetic nanowires, for the heating and actuation of thermoresponsive Poly(N-isopropylacrylamide) hydrogels (PNIPAm) in the form of nanoparticles in membranes and stand-alone microdroplets, and actuation of flexible membranes for drug pumping. Thermoresponsive PNIPAm, in any form such as nanoparticles, microdroplets, or mezzo scale bulk material shapes, has the property of swelling with water in its hydrophilic state below a critical temperature. At higher temperatures, a sharp change occurs, the polymer network becomes hydrophilic, and the water molecules in the network is expelled, causing the overall material to shrink in size, while the released water or aqueous solution is left free to flow around or away from the material. When embedded in membrane matrices used as drug delivery gates, PNIPAm nanoparticles act as diffusion and flow blockers below the critical temperature. When PNIPAm surpasses the critical temperature, induced by heat from local magnetic iron oxide nanoparticles (exposed to a 62 mT, 450 kHz magnetic field), it shrinks in size and increases the drug flow through membrane pathways. The combination of this membrane design with osmotic pumping and methods for tailoring the drug release profile is reported. Simulation supports experimental results while describing interactions between the osmotic pump and the thermoresponsive membranes. A sensitivity analysis based on a fluidic circuit analogy gives insight into the contributions of the components of the device, in particular those of membranes affecting the displacement of fluid. PNIPAm microdroplets, spherical microparticles larger than the PNIPAm nanoparticles discussed above, are fabricated with embedded magnetic iron oxide nanoparticles or magnetic iron nanowires and pre-loaded with an aqueous drug. Upon magnetic heating, these microdroplets shrink in size and expel the drug. Magnetic nanowires have much lower power requirements when compared with widely-used iron oxide magnetic nanoparticles for triggering PNIPAm, due to their ability to generate losses via physical vibration within the microdroplets. A model is used to corroborate the experimentally observed low power (1 mT, 20 kHz magnetic field) required to induce PNIPAm microdroplet shrinkage. This model for nanowire loaded microdroplet design is compared with the well-established theory for power generation from magnetic iron oxide nanoparticles, and associated experiments (using a 72 mT, 600 kHz magnetic field) in order to confirm the validity of the calculated power generated by iron nanowires. The findings in this work offer several flexible options for the application of PNIPAm as a remotely triggerable drug delivery controller or carrier, using relatively simple fabrication methods, permitting several degrees of customization of the delivery rate or profile by adjusting the PNIPAm material, its magnetic content, and the applied magnetic field, all the while demonstrating the use of magnetic nanowires as a more efficient power transfer material when compared to traditionally used magnetic nanoparticles. The findings associated with the efficient triggering of PNIPAm microdroplets can be implemented in a more power-friendly design of magnetic, remotely triggered membranes which, although implemented in conjunction with osmotic pumps here, can be coupled with other pressure sources.
Applied Science, Faculty of
Engineering, School of (Okanagan)
Graduate
Style APA, Harvard, Vancouver, ISO itp.
4

Squire, Marie A. "Protein-based drug delivery systems". Thesis, University of Canterbury. Chemistry, 2004. http://hdl.handle.net/10092/6518.

Pełny tekst źródła
Streszczenie:
The targeted delivery of drugs is one of the most actively pursued goals in anti-HIV and anti-cancer chemotherapy. This project takes a proof-of-concept approach to the development of protein-based drug delivery systems - delivery systems that would package, target, and deliver cytotoxins to diseased cells. Primarily, this project explores the use of the potent anti-HN protein, cyanovirin-N (CV-N), to actively target and deliver cytotoxic natural products to HN-infected cells. This project also investigates the use of human serum albumin (HSA), a 66 kDa protein, as a macromolecular carrier to passively target and deliver cytotoxic natural products to cancerous cells. To facilitate release of the toxin within infected cells, an enzymatically-cleavable tetra peptide was incorporated in the conjugates. Maleimido-activated tetra peptide toxin constructs were prepared in readiness for selective reaction with proteins carrying thiol functionalities. Release of the toxin, norhomohalichondrin B, was demonstrated in vitro. Native CV -N conjugates were prepared by thiolation of the lysine ε-amino groups, and the subsequent reaction with maleimido-activated compounds. Reaction across all lysine residues was demonstrated. A singly-substituted tyrosinamide conjugate of CV-N was prepared. Two recombinantly produced mutant CV-N proteins allowed for the production of selectively modified, double- and single-norhomohalichondrin B conjugates of CV-N. The conjugates retained the anti-HN activity of the parent protein. Homohalichondrin B, doxorubicin, and tyrosinamide conjugates of HSA were prepared. The syntheses exploited the availability of a free thiolmoiety at cysteine-34 of HSA, and the specific and selective reaction of this thiol with the maleimido-activated tetra peptide derivatives. All toxin conjugates demonstrate excellent cell toxicity. Further research to investigate whether this is targeted toxicity is currently underway.
Style APA, Harvard, Vancouver, ISO itp.
5

Muldoon, B. M. "Mucoadhesive systems for drug delivery". Thesis, Queen's University Belfast, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.268336.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Allen, Rosamund Elizabeth. "Liposomes as drug delivery systems". Thesis, University of Essex, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.352982.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Liu, Weipeng. "Biopolymer-based ocular drug delivery systems". Diss., Connect to online resource - MSU authorized users, 2008.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Rosenbaum, Erik. "Optical characterization of potential drugs and drug delivery systems". Doctoral thesis, Umeå universitet, Kemiska institutionen, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-40177.

Pełny tekst źródła
Streszczenie:
This Thesis is a characterization study on substances having potency as drugs as well as on a lipid based drug-delivery matrix. The optical properties of newly synthesized molecules with proven pilicide properties have been characterized with several spectroscopic methods. These methods include optical absorption and fluorescence as well as time-resolved fluorescence. Upon covalently linking compounds with high quantum yields of fluorescence to specific parts of the pilicide, the biological impact was found to increase for some of the derivatives. Furthermore, by expanding the aromatic part of the pilicide molecule, a significant increase in the inherent fluorescence was obtained. The S0-S1 absorption band for these molecules was found to originate from an impure electronic transition, vibronically promoted by intensity borrowing from higher electronic states. Included in this Thesis is the measurement of how deeply some in this class of newly synthesized molecules become situated when placed inside ganglioside GM1 micelles, and how the molecules’ reorientation is affected. By means of radiation-less energy transfer, it was shown that the molecules place themselves close to the hydrophobic-hydrophilic interface inside the GM1 micelles. As a consequence they are exposed to a densely packed environment, which inhibits the free tumbling of the molecule. This restricted tumbling could be measured by means of time-resolved depolarization experiments. The release of drug-like fluorescent molecules is investigated from a lipid mixture, which upon equilibrium with water forms a mixture of inverted hexagonal and cubic phases. The lipid matrix displayed an extended release over the course of weeks, in vitro, for molecules having a large variation in hydrophobicity.
Style APA, Harvard, Vancouver, ISO itp.
9

Zhao, Tianjing. "Self-nanoemulsifying drug delivery systems (SNEDDS) for the oral delivery of lipophilic drugs". Doctoral thesis, Università degli studi di Trento, 2015. https://hdl.handle.net/11572/369035.

Pełny tekst źródła
Streszczenie:
The increasing number of lipophilic drug candidates in development in the pharmaceutical industry calls for advanced drug delivery systems with increased bioavailability less day-to-day and food-intake-dependent. Many of these drug candidates possess poor water solubility, so that their dissolution rate in the gastrointestinal tract (GIT) limits their absorption following oral administration. In the past few decades, various lipid-based formulations have been investigated to enhance the bioavailability of such challenging drug candidates and to increase their clinical efficacy when administered orally. Recently, self-emulsifying drug delivery systems (SEDDS) have attracted increasing interests and, in particular, self-nanoemulsifying drug delivery systems (SNEDDS). SEDDS and SNEDDS consist in micro- or nano-emulsions of oil containing the drug that spontaneously form in aqueous media on mild agitation. Usually, they use high amounts of surfactant that may cause degradation and instability of the drugs, being moreover toxic for the gastrointestinal tract. The aim of the present thesis was the preparation of novel self-nanoemulsifying drug delivery systems to overcome the shortages of conventional SEDDS or SNEDDS. To reduce the amount of surfactant, we formulated first a self-nanoemulsifying drug delivery system containing high proportion of essential lemon oil, that was characterized in terms of drug solubility, formulation stability, viscosity, emulsion droplet size, ζ-potential and in vitro drug release. Then, a pH-sensitive SNEDDS was developed that emulsify only at basic pHs. The goal was to protect the lipophilic drugs from the harsh acidic environment in stomach and render it available in the enteric tract where the bioactive compound should be absorbed.
Style APA, Harvard, Vancouver, ISO itp.
10

Zhao, Tianjing. "Self-nanoemulsifying drug delivery systems (SNEDDS) for the oral delivery of lipophilic drugs". Doctoral thesis, University of Trento, 2015. http://eprints-phd.biblio.unitn.it/1608/1/Doctoral_thesis-Self-nanoemulsifying_drug_delivery_systems_(SNEDDS)_for_the_oral_delivery_of_lipophilic_drugs-Tianjing_ZHAO.pdf.

Pełny tekst źródła
Streszczenie:
The increasing number of lipophilic drug candidates in development in the pharmaceutical industry calls for advanced drug delivery systems with increased bioavailability less day-to-day and food-intake-dependent. Many of these drug candidates possess poor water solubility, so that their dissolution rate in the gastrointestinal tract (GIT) limits their absorption following oral administration. In the past few decades, various lipid-based formulations have been investigated to enhance the bioavailability of such challenging drug candidates and to increase their clinical efficacy when administered orally. Recently, self-emulsifying drug delivery systems (SEDDS) have attracted increasing interests and, in particular, self-nanoemulsifying drug delivery systems (SNEDDS). SEDDS and SNEDDS consist in micro- or nano-emulsions of oil containing the drug that spontaneously form in aqueous media on mild agitation. Usually, they use high amounts of surfactant that may cause degradation and instability of the drugs, being moreover toxic for the gastrointestinal tract. The aim of the present thesis was the preparation of novel self-nanoemulsifying drug delivery systems to overcome the shortages of conventional SEDDS or SNEDDS. To reduce the amount of surfactant, we formulated first a self-nanoemulsifying drug delivery system containing high proportion of essential lemon oil, that was characterized in terms of drug solubility, formulation stability, viscosity, emulsion droplet size, ζ-potential and in vitro drug release. Then, a pH-sensitive SNEDDS was developed that emulsify only at basic pHs. The goal was to protect the lipophilic drugs from the harsh acidic environment in stomach and render it available in the enteric tract where the bioactive compound should be absorbed.
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Drug delivery systems"

1

M, Ottenbrite Raphael, i Kim Sung Wan, red. Polymeric drugs & drug delivery systems. Lancaster, Pa: Technomic Pub. Co., 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Ranade, Vasant V. Drug delivery systems. Wyd. 3. Boca Raton: CRC Press, 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Jain, Kewal K., red. Drug Delivery Systems. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-210-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Jain, Kewal K., red. Drug Delivery Systems. New York, NY: Springer New York, 2020. http://dx.doi.org/10.1007/978-1-4939-9798-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

(Firm), Business Technology Research, red. Drug delivery systems. Wellesley Hills, MA: Business Technology Research, 1988.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Ranade, Vasant V. Drug delivery systems. Boca Raton, Fla: CRC Press, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Coghlan, Andy. Drug delivery systems. Letchworth: Society of Chemical Industry, 1985.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

K, Jain K., red. Drug delivery systems. Totowa, NJ: Humana, 2008.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

A, Hollinger Mannfred, red. Drug delivery systems. Wyd. 2. Boca Raton: CRC Press, 2004.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Popescu, Maria A. Drug delivery. Hauppauge, N.Y: Nova Science Publishers, 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Drug delivery systems"

1

Holowka, Eric P., i Sujata K. Bhatia. "Controlled-Release Systems". W Drug Delivery, 7–62. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-1998-7_2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Hombach, Juliane, i Andreas Bernkop-Schnürch. "Mucoadhesive Drug Delivery Systems". W Drug Delivery, 251–66. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-642-00477-3_9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Holowka, Eric P., i Sujata K. Bhatia. "Smart Drug Delivery Systems". W Drug Delivery, 265–316. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-1998-7_7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Janapareddi, Krishnaveni, Bhaskara R. Jasti i Xiaoling Li. "Evolution of Controlled Drug Delivery Systems". W Drug Delivery, 336–52. Hoboken, NJ: John Wiley & Sons, Inc, 2016. http://dx.doi.org/10.1002/9781118833322.ch15.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Shakesheff, Kevin M. "Drug Delivery Systems". W Handbook of Biodegradable Polymers, 363–78. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2011. http://dx.doi.org/10.1002/9783527635818.ch15.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Ito, Yoshihiro. "Drug Delivery Systems". W Photochemistry for Biomedical Applications, 231–75. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-0152-0_9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Bondi, Joseph V., i D. G. Pope. "Drug Delivery Systems". W Drug Discovery and Development, 291–325. Totowa, NJ: Humana Press, 1987. http://dx.doi.org/10.1007/978-1-4612-4828-6_11.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Barnes, Peter J., i Simon Godfrey. "Drug delivery systems". W Chronic Obstructive Pulmonary Disease: pocketbook, 33–38. London: CRC Press, 2023. http://dx.doi.org/10.1201/9781003420316-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Bodor, N., i M. E. Brewster. "Chemical Delivery Systems". W Targeted Drug Delivery, 231–84. Berlin, Heidelberg: Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-75862-1_7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

De Andrés, José, Rubén Rubio-Haro, Carmen De Andres-Serrano, Juan Marcos Asensio-Samper i Gustavo Fabregat-Cid. "Intrathecal Drug Delivery". W Drug Delivery Systems, 75–108. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9798-5_3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Drug delivery systems"

1

Ruiz, Alberto J., Edwin A. Robledo, Eammon Littler i Ethan P. M. LaRochelle. "Radiometric characterization methods for fluorescence guidance imaging systems using a calibrated solid-state emitter". W Optical Molecular Probes, Imaging and Drug Delivery. Washington, D.C.: Optica Publishing Group, 2023. http://dx.doi.org/10.1364/omp.2023.oth1e.5.

Pełny tekst źródła
Streszczenie:
Methods for radiometric characterization of fluorescence-guided imaging systems using a calibrated solid-state emitter are introduced. Used alongside fluorescence phantoms, we demonstrate quantitative fluorescence imaging that can facilitate cross-system comparisons and multi-center reproducibility.
Style APA, Harvard, Vancouver, ISO itp.
2

Marriott, Gerard, i Yuling Yan. "New Probes for High-contrast Imaging and Manipulation of Biomolecules within Living Systems". W Optical Molecular Probes, Imaging and Drug Delivery. Washington, D.C.: OSA, 2013. http://dx.doi.org/10.1364/omp.2013.mth1c.1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Lin, Michael. "Visualizing Electrical Activity in Neural Systems Using a New Family of Fast Genetically Encoded Voltage Indicators". W Optical Molecular Probes, Imaging and Drug Delivery. Washington, D.C.: OSA, 2015. http://dx.doi.org/10.1364/omp.2015.jw2b.2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

George, Ashline, i Jerin Cyriac. "Nano particle based drug delivery systems". W 2017 Third International Conference on Advances in Electrical, Electronics, Information, Communication and Bio-Informatics (AEEICB). IEEE, 2017. http://dx.doi.org/10.1109/aeeicb.2017.7972386.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Chen, Michael. "Nanotechnologies for Advanced Drug Delivery Systems". W The 5th World Congress on New Technologies. Avestia Publishing, 2019. http://dx.doi.org/10.11159/icbb19.02.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Bellazzi, R. "Predictive fuzzy controllers for drug delivery". W Second International Conference on `Intelligent Systems Engineering'. IEE, 1994. http://dx.doi.org/10.1049/cp:19940635.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Terracciano, M., L. De Stefano, H. A. Santos, A. Lamberti, N. M. Martucci, M. A. Shahbazi, A. Correia, I. Ruggiero, I. Rendina i I. Rea. "Diatomite nanoparticles as potential drug delivery systems". W 2015 International Conference on BioPhotonics (BioPhotonics). IEEE, 2015. http://dx.doi.org/10.1109/biophotonics.2015.7304032.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Choudhary, S., J. M. Reck i S. R. Bhatia. "Hydrophobically modified alginate for drug delivery systems". W 2009 IEEE 35th Annual Northeast Bioengineering Conference. IEEE, 2009. http://dx.doi.org/10.1109/nebc.2009.4967735.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Meng, Ellis. "Polymer BioMEMS for implantable drug delivery systems". W 2009 4th IEEE International Conference on Nano/Micro Engineered and Molecular Systems. IEEE, 2009. http://dx.doi.org/10.1109/nems.2009.5068786.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Ortiz-Lopez, Keishla D., Mahima Agumbe Suresh i Radu Stoleru. "Transmitters location optimization for drug delivery systems". W NANOCOM '18: ACM The Fifth Annual International Conference on Nanoscale Computing and Communication. New York, NY, USA: ACM, 2018. http://dx.doi.org/10.1145/3233188.3233213.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Drug delivery systems"

1

Zarabi, Bahar, i Hamid Ghandehari. Magnetic Resonance Imaging of Polymeric Drug Delivery Systems in Breast Cancer Solid Tumors. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2005. http://dx.doi.org/10.21236/ada439254.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Popova, Teodora, Borislav Tzankov, Christina Voycheva, Krassimira Yoncheva i Nikolai Lambov. Development of Advanced Drug Delivery Systems with Bicalutamide Based on Mesoporous Silica Particles. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, grudzień 2019. http://dx.doi.org/10.7546/crabs.2019.12.08.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Zarabi, Bahar, i Hamid Ghandehari. Magnetic Resonance Imaging of Polymeric Drug Delivery Systems in Breast Cancer Solid Tumors. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2006. http://dx.doi.org/10.21236/ada469974.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Zarabi, Bahar. Magnetic Resonance Imaging of Polymeric Drug Delivery Systems in Breast Cancer Solid Tumors. Fort Belvoir, VA: Defense Technical Information Center, grudzień 2007. http://dx.doi.org/10.21236/ada480781.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Dżaman, Karolina, i Katarzyna Czerwaty. Extracellular Vesicle-Based Drug Delivery Systems for Head and Neck Squamous Cell Carcinoma: A Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, kwiecień 2023. http://dx.doi.org/10.37766/inplasy2023.4.0021.

Pełny tekst źródła
Streszczenie:
Review question / Objective: This systematic review aims to identify studies investigating the membrane vesicle-based drug de-livery systems (DDS) for HNSCC and define the potential of extracellular vesicles (EVs) in the treatment of this disease according to the current state of knowledge. Condition being studied: Head and neck squamous cell carcinoma (HNSCC), which is ranked the sixth most common malignancy worldwide, originates in the epithelium of the oral and nasal cavities, pharynx, and larynx. The treatment of HNSCC remains a challenge and requires the involvement of a multidisciplinary team. Currently available methods of treatment, such as surgery, radiotherapy, and chemotherapy, cause significant dysfunctions and toxicity, which highlights the necessity to explore new therapeutic options. One-third of patients treated with intended curative surgery and adjuvant therapy experience local or regional recurrence and/or distant metastasis.
Style APA, Harvard, Vancouver, ISO itp.
6

McPhillips, D. M., M. W. Price, J. W. Gibson i R. A. Casper. Development of an On-Demand, Generic, Drug-Delivery System. Fort Belvoir, VA: Defense Technical Information Center, sierpień 1985. http://dx.doi.org/10.21236/ada158550.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Pflugfelder Ghanashyam S., Stephen C. Broadly Applicable Nanowafer Drug Delivery System for Treating Eye Injuries. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 2014. http://dx.doi.org/10.21236/ada613401.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Dash, Alekha K. Novel in Situ Gel Drug Delivery System for Breast Cancer Treatment. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2007. http://dx.doi.org/10.21236/ada474685.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Silva, João, Matheus Warmeling i Rogério Pagnoncelli. Platelet-rich fibrin as a drug delivery system: a scoping review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, sierpień 2023. http://dx.doi.org/10.37766/inplasy2023.8.0004.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Basu, Sayani. Nanoparticle-Based Therapeutics for the Treatment of Stroke. Nature Library Ltd, listopad 2020. http://dx.doi.org/10.47496/nl.blog.13.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Drug delivery systems” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii